We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Official: Make Minutes From Agency, Sponsor Meetings Public
FDA Official: Make Minutes From Agency, Sponsor Meetings Public
January 4, 2012
CDER should be allowed to release minutes from its meetings with sponsors during the drug approval process so that a more accurate account of the interactions is made public and the FDA can defend itself against accusations that it shifted its expectations during reviews, an FDA official says.